US 7,351,419 B2Granted

Oral pharmaceutical suspension of Cefdinir crystal

AssigneeAstellas Pharma Inc.

InventorsNaozumi Ohnishi, Shuhei Deguchi, Satoshi Kitamura

Life of this patent

Estimating the term…

Abstract

The present invention relates to a novel oral pharmaceutical suspension of Cefdinir crystal. More specifically, the present invention relates to a novel kit for preparation of an oral pharmaceutical suspension containing crystal form C Cefdinir.

Claims24

Dependent claims

An oral pharmaceutical suspension comprising crystal form C of Cefdinir, and a pharmaceutically acceptable aqueous carrier.

Dependencies are inferred from the claim text.

Facts

Application: 11/289,333Filed 30 Nov 2005 · us provisional application
Priority: 30 Nov 2004
Published: US 2006/0135500 A122 Jun 2006
Granted: 1 Apr 2008
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

C07D 501/00
Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a
A61K 9/0095
Galenical forms not covered by A61K9/02 - A61K9/7023: drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets…
A61K 31/545
Ortho- or peri-condensed with heterocyclic ring systems: compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds…
A61K 31/546
Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: [IMAGE…: containing…

Family

Application60/631,628Us provisional application · filed 30 Nov 2004
US 2006/0135500 A1Pre-grant publication · published 22 Jun 2006
US 7,351,419 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results